Erosive Esophagitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis
Condition: Chinese Patients With Erosive Esophagitis (EE) Intervention: Drug: LXI-15028 Sponsor: Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 6, 2018 Category: Research Source Type: clinical trials
Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis
Condition: Erosive Esophagitis (EE) Interventions: Drug: LXI-15028 50mg; Drug: Esomeprazole 40mg Sponsor: Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 6, 2018 Category: Research Source Type: clinical trials